Latest ACR News
-
A matched cohort study from the Veterans Health Administration shows that rheumatoid arthritis patients have a >50% increased risk of lung cancer, and a 3-fold higher risk of lung cancer in RA-interstitial lung disease (ILD).Read Article
Mike Putman EBRheum
5 years 1 month ago
#ACR19 Abst#2878 #ACRbest - Tildrakizumab (IL23i) RCT
Good ACR20 (80% v 51%, NNT ~3) regardless of dose; great safety profile. Curiously high PLBO response, expectation bias?
PASI75 phenomenal per usual (80% v 17% plbo, NNT 1-2)
Need IL23/IL17/TNF comparative study!
@RheumNow https://t.co/uEGvsD8KVb
Mike Putman EBRheum
5 years 1 month ago
#ACR19 Guidelines for OA: my take home is this truly astonishing funnel plot
Virtually zero small negative studies and dozens of small positive studies
Clear trend toward NO effect w/more precision in trial
Publication bias et al. in action!! @RheumNow https://t.co/65nKzghobz
Olga Petryna DrPetryna
5 years 1 month ago
@RheumNow #acr19 abs2876 GODACT ph3 trial: glimumab+MTX improves clinical& MRI dactylitis scores better than MTX mono. mean MTX dose in the golimumab+ MTX group 16.3mg/wk & 19.2mg/wk in the MTX mono group . Also better DAS28,DAPSA,PASDAS& tNAPSI at wk 24 in golimumab group
Janet Pope Janetbirdope
5 years 1 month ago
Practical tips for Raynauds in curbside consults. If Raynauds onsets at age less than 40 and no symptoms or signs of secondary causes such as CTD and normal nailfold capillaries likely no investigations are needed 5T118 #ACR #ACR19 #Scleroderma @RheumNow https://t.co/59gnI5ECNZ
Jonathan Hausmann MD hausmannMD
5 years 1 month ago
”...too much attention to developing the memory and not enough to developing the mind.” William J. Mayo, 1933.
Couldn't have said it better myself. Remains a challenge in #MedEd to this day.
#ACR19 @RheumNow
Dr. John Cush RheumNow
5 years 1 month ago
Very important. https://t.co/WjdMSsXc4S
Dr. John Cush RheumNow
5 years 1 month ago
RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow and its faculty.
Dr. Paul Sufka psufka
5 years 1 month ago
#ACR19 Review Course — Update in RA Therapy 2019 — Dr. Michael Weinblatt.
My notes in thread ⬇️⬇️⬇️
Dr. Arthur Lau ArthurRheum
5 years 1 month ago
From CORRONA registry- TCZ plus MTX similar drug survival compared to TBF plus MTX in TNFIR https://t.co/iDdYIoBlWo @RheumNow #ACR19
Dr. Arthur Lau ArthurRheum
5 years 1 month ago
OLE data shows Tx with Sarilumab improved likelihood of glucocorticoid dose reduction with 16% able to discontinue @RheumNow #ACR19 https://t.co/YWetjp5Rlp
Janet Pope Janetbirdope
5 years 1 month ago
Should we measure vit D in all pregnant women with SLE? As in general population low vitamin D increased miscarriage and preterm births. Weird as so did high vitamin D. Abstr 2531 #ACR #ACR19 @RheumNow #SLE #sle https://t.co/Mwb3WoCyBA
David Liew drdavidliew
5 years 1 month ago
@Drbeckyg featured in the ACR Rheumatology Round-up!! Makes us think about how we might engage patients better in their disease assessment...
#ACR19 ABST1366 @RheumNow https://t.co/47DfV7RH1s https://t.co/MZarkQkDdb
Dr Irwin Lim _connectedcare
5 years 1 month ago
Ken Cai, Aussie presenting NZ research
#ACR19 @earlyara Abst2732 https://t.co/K7mltsR8q3
Dr Irwin Lim _connectedcare
5 years 1 month ago
Size of M protein, type & abnormal free light chain protein ratio allows prognostication for MGUS
#ACR19 @rheumnow 5T064
Kanika Monga, MD DrKanikaMonga
5 years 1 month ago
What contributes to serious infections in RA? Higher inflammation and GC use, not bDMARD or tofacitinib use increased infectious risk
Bella Mehta et al. RMD Open 2019
#ACR19 @RheumNow